Lucid Diagnostics Inc (LUCD)

May 22, 2026

LUCD News | LUCID DIAGNOSTICS INC (NASDAQ:LUCD) - ChartMill

May 22, 2026

May 21, 2026

Director buys 245K Lucid Diagnostics (NASDAQ: LUCD) shares in market - Stock Titan

May 21, 2026

May 17, 2026

Lucid Diagnostics Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:LUCD) 2026-05-17 - Seeking Alpha

May 17, 2026

May 17, 2026

Lucid Diagnostics Inc. (LUCD) reports Q1 loss, misses revenue estimates - MSN

May 17, 2026

May 15, 2026

PAVmed Inc (PAVM) Q1 2026 Earnings Call Highlights: Strategic Restructuring and Growth ... By GuruFocus - Investing.com Canada

May 15, 2026

May 15, 2026

Upcoming Events - FinancialContent

May 15, 2026

May 15, 2026

Maxim Group Maintains Lucid Diagnostics(LUCD.US) With Buy Rating, Cuts Target Price to $2 - Moomoo

May 15, 2026

May 15, 2026

BTIG Maintains Lucid Diagnostics(LUCD.US) With Buy Rating, Maintains Target Price $2.5 - Moomoo

May 15, 2026

May 15, 2026

PAVmed (PAVM) Q1 2026 Earnings Transcript - AOL.com

May 15, 2026

May 15, 2026

PAVmed (PAVM) Q4 2025 Earnings Transcript - The Globe and Mail

May 15, 2026

May 15, 2026

PAVmed Reports Q1 2026 Financial Results, Highlights Progress in Veris Health FDA Submission and Lucid Diagnostics Commercial Expansion - Minichart

May 15, 2026

May 15, 2026

Earnings Call Summary | Lucid Diagnostics(LUCD.US) Q1 2026 Earnings Conference - 富途牛牛

May 15, 2026

May 15, 2026

PAVmed Reports Wider-than-Expected Q1 2026 Loss - AlphaStreet

May 15, 2026

May 15, 2026

Earnings call transcript: PAVmed Inc. Q1 2026 shows restructuring gains By Investing.com - Investing.com Australia

May 15, 2026

May 15, 2026

Earnings call transcript: PAVmed Inc. Q1 2026 shows restructuring gains - Investing.com India

May 15, 2026

May 15, 2026

Q1 2026 PAVmed Inc Earnings Call Transcript - GuruFocus

May 15, 2026

May 15, 2026

Lucid Diagnostics Inc. (NASDAQ:LUCD) Q1 2026 Earnings Call Transcript - Insider Monkey

May 15, 2026

May 15, 2026

PAVmed (NASDAQ: PAVM) Q1 2026 results, losses and cash position - Stock Titan

May 15, 2026

May 15, 2026

PAVmed Q1: cancer test and implantable monitor push toward coverage, FDA - Stock Titan

May 15, 2026

May 15, 2026

Canaccord Genuity Sticks to Its Buy Rating for Lucid Diagnostics (LUCD) - The Globe and Mail

May 15, 2026

May 15, 2026

Lucid says $44.8M pro forma cash extends runway well into 2027 as it awaits Medicare LCD - MSN

May 15, 2026

May 15, 2026

Lucid Diagnostics Inc.Common Stock (NQ: LUCD - FinancialContent

May 15, 2026

May 14, 2026

PAVmed Inc.Series Z Warrant (NQ: PAVMZ - FinancialContent

May 14, 2026

May 14, 2026

Lucid Diagnostics Earnings Call Balances Progress, Pressure - TipRanks

May 14, 2026

May 14, 2026

PAVmed Reports Business Expansion and Financial Update - Intellectia AI

May 14, 2026

May 14, 2026

PAVmed (NASDAQ: PAVM) posts Q1 2026 loss and flags going concern risks - Stock Titan

May 14, 2026

May 14, 2026

Lucid Diagnostics Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

May 14, 2026

May 14, 2026

Lucid Diagnostics Releases Q1 2026 Financial Results - AlphaStreet

May 14, 2026

May 14, 2026

LUCD Q1 2026 Earnings Transcript - The Globe and Mail

May 14, 2026

May 14, 2026

Lucid Diagnostics Q1 Earnings Call Highlights - Yahoo Finance

May 14, 2026

May 14, 2026

LUCD: Q1 revenue reached $1.3M on 3,177 tests, with cash runway extended and Medicare approval pending - TradingView

May 14, 2026

May 14, 2026

Lucid Diagnostics Reports Q1 2026 Financial Results: $1.3M Revenue, Strong Cash Position, and Medicare Reimbursement Milestone Progress - Minichart

May 14, 2026

May 14, 2026

Earnings call transcript: Lucid Diagnostics Q1 2026: Revenue Miss Despite EPS Match - Investing.com

May 14, 2026

May 14, 2026

LUCD: Q1 2026 delivered strong test volume, improved cash, and progress toward Medicare and VA revenue - TradingView

May 14, 2026

May 14, 2026

Lucid Diagnostics earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada

May 14, 2026

May 14, 2026

Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

May 14, 2026

May 14, 2026

Lucid Diagnostics Reports Q1 2026 Results and Outlook - TipRanks

May 14, 2026

May 14, 2026

LUCID DIAGNOSTICS ($LUCD) Releases Q1 2026 Earnings - Quiver Quantitative

May 14, 2026

May 14, 2026

Lucid Diagnostics (NASDAQ: LUCD) narrows loss and extends cash runway into 2027 - Stock Titan

May 14, 2026

May 14, 2026

Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results - marketscreener.com

May 14, 2026

May 14, 2026

Lucid Diagnostics (LUCD) Q1 Loss Widening To US$23.6 Million Tests Bullish Growth Narrative - Sahm

May 14, 2026

May 13, 2026

Lucid Diagnostics 1Q 2026: Revenue $1.26M, EPS ($0.17) — 10-Q Summary - TradingView

May 13, 2026

May 13, 2026

LUCD: Q1 2026 saw higher revenue but continued losses, with future viability hinging on reimbursement and capital - TradingView

May 13, 2026

May 13, 2026

Lucid Diagnostics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 13, 2026

May 13, 2026

Lucid Diagnostics (NASDAQ: LUCD) grows Q1 revenue but flags going-concern risk - Stock Titan

May 13, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 11, 2026

Fat Pitch FinancialsLucid Diagnostics Inc.Common Stock (Nasdaq:LUCD) Stock Quote - FinancialContent

May 11, 2026

May 11, 2026

Lucid Diagnostics Inc. (LUCD) may report negative earnings: Know the trend ahead of next week's release - MSN

May 11, 2026

May 09, 2026

Lucid Diagnostics (NASDAQ:LUCD) Stock Rating Lowered by Wall Street Zen - MarketBeat

May 09, 2026

May 08, 2026

Lucid Diagnostics Inc. (LUCD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance

May 08, 2026

May 07, 2026

Lucid Diagnostics (LUCD) to Release Earnings on Thursday - MarketBeat

May 07, 2026

May 06, 2026

Q3 2025 PAVmed Inc Earnings Call Transcript - GuruFocus

May 06, 2026

May 06, 2026

Lucid Diagnostics Inc. (LUCD) reports Q4 loss, beats revenue estimates - MSN

May 06, 2026